Medically Attended Respiratory Syncytial Virus Infections in Adults Aged >=50 Years: Clinical Characteristics and Outcomes
Open Access
- 21 November 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 58 (3) , 342-349
Abstract
Background. Few studies have examined respiratory syncytial virus (RSV) infections in adults. We assessed the characteristics and outcomes of RSV relative to other viral infections. Methods. Patients ≥50 years old with acute respiratory illness were recruited for studies of influenza vaccine effectiveness from 2004 through 2010. Nasopharyngeal swabs from enrollees were analyzed for the presence of RSV and other respiratory viruses by multiplex reverse transcription polymerase chain reaction. Clinical data were obtained from interview and medical records. Results. A total of 2225 samples were tested across all seasons. The mean age was 64.2 (SD, 10.7) years; the mean interval from illness onset to sample collection was 4 (SD, 2.2) days. One or more viruses were detected in 1202 (54%) participants. In a multivariable logistic regression model, RSV was associated with ages 65–79 years (vs 50–64 years), symptoms of cough, nasal congestion and wheezing, and longer interval from illness onset to clinical encounter. RSV was not associated with the presence of chronic obstructive pulmonary disease or congestive heart failure in univariate analyses. Hospital admission within 30 days after illness onset was less common among patients with RSV compared to those with influenza (unadjusted odds ratio = 0.54 [95% confidence interval, .29–1.01], P = .06). Conclusions. RSV is a common cause of acute respiratory illness in adults aged ≥50 years; the risk of infection increases with age. Delays in healthcare seeking and reduced risk of hospital admission in patients with RSV suggest a milder course of illness relative to influenza.Keywords
This publication has 21 references indexed in Scilit:
- Rates of Hospitalizations for Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza Virus in Older AdultsThe Journal of Infectious Diseases, 2012
- Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993–2008Clinical Infectious Diseases, 2012
- Influenza vaccine effectiveness in Wisconsin during the 2007–08 season: Comparison of interim and final resultsVaccine, 2011
- Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 U.S. CommunitiesPLOS ONE, 2011
- Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004–2005 Season to the 2006–2007 SeasonThe Journal of Infectious Diseases, 2009
- Is Clinical Recognition of Respiratory Syncytial Virus Infection in Hospitalized Elderly and High‐Risk Adults Possible?The Journal of Infectious Diseases, 2007
- Respiratory Syncytial Virus Infection in Elderly and High-Risk AdultsNew England Journal of Medicine, 2005
- Risk Factors for Severe Respiratory Syncytial Virus Infection in Elderly PersonsThe Journal of Infectious Diseases, 2004
- Measuring Disease Frequency in the Marshfield Epidemiologic Study Area (MESA)Clinical Medicine & Research, 2003
- Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational studyThe Lancet, 2001